# Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes

> **NCT02392156** · — · TERMINATED · sponsor: **Bioverativ Therapeutics Inc.** · enrollment: 3 (actual)

## Conditions studied

- Hemophilia A
- Hemophilia B

## Interventions

- **BIOLOGICAL:** rFVIIIFc
- **BIOLOGICAL:** rFIXFc
- **DRUG:** non-Fc FVIII replacement products
- **DRUG:** non-Fc FIX replacement products

## Key facts

- **NCT ID:** NCT02392156
- **Lead sponsor:** Bioverativ Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study terminated due to recruitment challenges.
- **Last updated:** 2020-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02392156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02392156, "Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02392156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*